Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Rifamycins

Known as: Rifamycin, Rifamycins [Chemical/Ingredient], 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-B)furan-1,11(2h)-dione 21-Acetate 
A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial drug that inhibits… Expand
National Institutes of Health

Related topics

Related topics

46 relations

Narrower (34)

27-O-demethylrifamycin S3-hydrazinorifamycinABI 0043ABI 1131
Expand

Broader (3)

Anti-Bacterial AgentsAntibioticsNaphthols
In BloodPoisoning by rifamycinsRifampinagonists
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae
SUMMARY Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in the 2000s as important human… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Review
2009
Review
2009
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine…
This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs… Expand
  • table 1
  • table 1
  • table 3
  • table 4
  • table 4
Review
2008
Review
2008
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described… Expand
  • table 1
  • figure 1
Highly Cited
2004
Highly Cited
2004
Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain
ABSTRACT The occurrence of extended-spectrum β-lactamase (ESBL)-producing isolates has increased worldwide. Fecal carriage of… Expand
Highly Cited
2002
Highly Cited
2002
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
The antibiotics rifamycin SV and rifampicin substantially reduce sulfobromophthalein (BSP) elimination in humans. In rats… Expand
Highly Cited
2002
Highly Cited
2002
Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals.
Nine clinical isolates of Enterobacteriaceae (six Escherichia coli and three Proteus mirabilis) isolated in three Parisian… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Review
2001
Review
2001
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
The rifamycin antibacterials, rifampicin (rifampin), rifabutin and rifapentine, are uniquely potent in the treatment of patients… Expand
Highly Cited
1999
Highly Cited
1999
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid
BACKGROUND Rifapentine is a cyclopentyl-substituted rifamycin whose serum half-life is five times that of rifampin. The US Public… Expand
Review
1998
Review
1998
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Knowledge of the molecular genetic basis of resistance to antituberculous agents has advanced rapidly since we reviewed this… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Highly Cited
1998
Highly Cited
1998
Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis
ABSTRACT The contributions of 23 insertion, deletion, or missense mutations within an 81-bp fragment of rpoB, the gene encoding… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE